Diabetes mellitus refers to a group of metabolic disorders which affect how the body uses
glucose impacting approximately 9% of the population worldwide. This review covers the …

A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and
Future of Intensive Therapy - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

OBJECTIVE Advances in diabetes technology have transformed the treatment paradigm for
type 1 diabetes, yet the burden of disease is significant. We report on a pivotal safety study …

Objective: To evaluate the safety of in-home use of the MiniMed™ 670G system with
SmartGuard™ technology in children with type 1 diabetes (T1D). Methods: Participants (N …

Background Highly variable insulin sensitivity, susceptibility to hypoglycemia and inability to
effectively communicate hypoglycemic symptoms pose significant challenges for young …

Automated insulin delivery (AID) systems, so-called closed-loop systems or artificial
pancreas, are based upon the concept of insulin supply driven by blood glucose levels and …

Background: The objective of this study was to assess the safety and effectiveness of the first
commercial configuration of a tubeless automated insulin delivery system, Omnipod® 5, in …

Introduction Type 1 diabetes is a lifelong disease with high management burden. The
majority of people with type 1 diabetes fail to achieve glycemic targets. Algorithm-driven …

Diabetes technology has continually evolved over the years to improve quality of life and
ease of care for affected patients. Frequent blood glucose (BG) checks and multiple daily …

Objective Artificial pancreas is a technology that minimizes user input by bridging
continuous glucose monitoring and insulin pump treatment, and has proven safety in the …